i2i, Inc.
2
1M
2
0.20
2
- Areas of investment
Summary
In 2012 was created i2i, Inc., which is appeared as Corporate Investor. The company was established in North America in United States. The main department of described Corporate Investor is located in the Dallas.
The standard case for the fund is to invest in rounds with 2 partakers. Despite the i2i, Inc., startups are often financed by i2E, SeedStep Angels, Oklahoma Seed Capital Fund. The meaningful sponsors for the fund in investment in the same round are i2E, SeedStep Angels.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Moleculera Labs. Among the most popular fund investment industries, there are Pharmaceutical, Health Care.
Deals in the range of 1 - 5 millions dollars are the general things for fund. The important activity for fund was in 2015. The fund is generally included in less than 2 deals every year.
The fund was created by Masoud Vaziri.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 2
- Rounds per year
- 0.20
- Investments by industry
- Medical (2)
- Biotechnology (2)
- Pharmaceutical (1)
- Health Care (1)
- Health Diagnostics (1)
- Investments by region
-
- United States (2)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 10
- Group Appearance index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Biolytx Pharmaceuticals | 06 Nov 2015 | Biotechnology, Health Care, Medical, Pharmaceutical | Seed | 1M | United States, Oklahoma, Oklahoma City |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.